Dual-task Training Combined With tDCS on Cognitive-motor Performance and Brain Activity in Stroke Patients
NCT06769672, Not applicable, Recruiting, The Hong Kong Polytechnic University
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Dual-task Training Combined With tDCS on Cognitive-motor Performance and Brain Activity in Stroke Patients | ClinicalTrials.gov |
| NCT number | NCT06769672 | ClinicalTrials.gov |
| Status | Recruiting | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 72 participants, estimated | ClinicalTrials.gov |
| Lead sponsor | The Hong Kong Polytechnic University | ClinicalTrials.gov |
| Conditions | Stroke, Cortical Excitability | ClinicalTrials.gov |
| Interventions | active tDCS with dual-task training, sham tDCS with dual-task training | ClinicalTrials.gov |
| First posted | 2025-01-10 | ClinicalTrials.gov |
| Last updated | 2026-10-14 | ClinicalTrials.gov |
Registered outcomes 23
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Dual-task self-paced walking--gait speed | Through study completion, an average of 1 year | Gait speed under dual-task walking condition will be recorded | ClinicalTrials.gov |
| Primary | Dual-task self-paced walking--cognitive performance | Through study completion, an average of 1 year | Number of correct responses will be measured during dual-task conditions | ClinicalTrials.gov |
| Secondary | Dual-task self-paced walking--gait performance 1 | Through study completion, an average of 1 year | Gait cadence will be measured during dual-task walking | ClinicalTrials.gov |
| Secondary | Dual-task self-paced walking--gait performance 2 | Through study completion, an average of 1 year | Stride length will be measured during dual-task walking | ClinicalTrials.gov |
| Secondary | Dual-task self-paced walking--gait performance 3 | Through study completion, an average of 1 year | Dor-Plantar Range under dual-task walking will be recorded | ClinicalTrials.gov |
| Secondary | Dual-task self-paced walking--cognitive performance 1 | Through study completion, an average of 1 year | Correct reaction time under dual-task walking will be recorded | ClinicalTrials.gov |
| Secondary | Oxyhemoglobin concentration changes of the brain | Through study completion, an average of 1 year | Oxyhemoglobin concentration changes will be measured using functional near infra-red spectroscopy during dual-task walking | ClinicalTrials.gov |
| Secondary | Dual-task pedaling--cadence | Through study completion, an average of 1 year | cadence under dual-task foot pedaling will be recorded | ClinicalTrials.gov |
| Secondary | Dual-task pedaling--cognitive performance 1 | Through study completion, an average of 1 year | Number of correct responses under dual-task foot pedaling will be recorded | ClinicalTrials.gov |
| Secondary | Blood oxygenation level changes of the brain | Through study completion, an average of 1 year | Blood oxygenation level changes will be measured using Magnetic Resonance Imaging during dual-task foot pedaling | ClinicalTrials.gov |
| Secondary | tDCS adverse event | Through study completion, an average of 1 year | number of patients who report an adverse event will be recorded. | ClinicalTrials.gov |
| Other | Dual-task pedaling--peak angular velocity | Through study completion, an average of 1 year | Peak angular (dorsi-plantar flexion) velocity under dual-task foot pedaling will be recorded | ClinicalTrials.gov |
| Other | Dual-task pedaling--Dorsi and Plantar range | Through study completion, an average of 1 year | Dorsi and Plantar range during dual-task foot pedaling will be recorded | ClinicalTrials.gov |
| Other | Dual-task walking--truning mobility | Through study completion, an average of 1 year | number of steps in turn will be recorded during dual-task walking | ClinicalTrials.gov |
| Other | Single-task walking speed | Through study completion, an average of 1 year | 10-meter walking test will be used to assess single-task walking speed in meters per second | ClinicalTrials.gov |
| Other | Balance 1 | Through study completion, an average of 1 year | Mini Balance Evaluation Systems Test will be used to assess postural control, with total points from 0-28. Higher points indicate better performance. | ClinicalTrials.gov |
| Other | Balance 2 | Through study completion, an average of 1 year | Activities-specific Balance Confidence Scale will be used to assess confidence of functional balance performance, with total points from 0-100. Higher points indicate better performance. | ClinicalTrials.gov |
| Other | Cognitive performance | Through study completion, an average of 1 year | Stroop color word test will be used to assess executive function | ClinicalTrials.gov |
| Other | Cognitive performance 1 | before the initiation of training | Montreal Cognitive Assessment will be used to assess global cognition, with total points from 0-30. Higher points indicate better performance. | ClinicalTrials.gov |
| Other | Cognitive performance 2 | Through study completion, an average of 1 year | Trail Making Test will be used to assess executive function | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 0
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 3
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|---|---|
| Stroop Color-Word Test | Other outcome | ConductCognition |
| Trail Making Test A | Other outcome | ConductCognition |
| Trail Making Test B | Other outcome | ConductCognition |
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)